{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:28:00Z","timestamp":1793284080822,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s10067-021-05774-9","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T06:03:04Z","timestamp":1621317784000},"page":"4427-4435","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Disease activity indices in psoriatic arthritis: current and evolving concepts"],"prefix":"10.1007","volume":"40","author":[{"given":"Chrysoula G.","family":"Gialouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Fragoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,18]]},"reference":[{"key":"5774_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA (2017) Gladman DD Psoriatic arthritis. N Engl J Med 376:957\u2013970. https:\/\/doi.org\/10.1056\/NEJMra1505557","journal-title":"N Engl J Med"},{"key":"5774_CR2","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H (2006) Group CS Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"key":"5774_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41584-018-0006-8","volume":"14","author":"J Feld","year":"2018","unstructured":"Feld J, Chandran V, Haroon N, Inman R (2018) Gladman D Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol 14:363\u2013371. https:\/\/doi.org\/10.1038\/s41584-018-0006-8","journal-title":"Nat Rev Rheumatol"},{"key":"5774_CR4","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.clim.2020.108397","volume":"214","author":"LM Perez-Chada","year":"2020","unstructured":"Perez-Chada LM (2020) Merola JF Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol 214:108397. https:\/\/doi.org\/10.1016\/j.clim.2020.108397","journal-title":"Clin Immunol"},{"key":"5774_CR5","doi-asserted-by":"publisher","first-page":"1759720X2097697","DOI":"10.1177\/1759720X20976975","volume":"12","author":"GE Fragoulis","year":"2020","unstructured":"Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, Iliopoulos A, Chatzidionysiou K, Sfikakis PP (2020) Tektonidou MG Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis 12:1759720X20976975. https:\/\/doi.org\/10.1177\/1759720X20976975","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5774_CR6","doi-asserted-by":"publisher","first-page":"839425","DOI":"10.1155\/2012\/839425","volume":"2012","author":"PC Wong","year":"2012","unstructured":"Wong PC, Leung YY, Li EK (2012) Tam LS Measuring disease activity in psoriatic arthritis. Int J Rheumatol 2012:839425. https:\/\/doi.org\/10.1155\/2012\/839425","journal-title":"Int J Rheumatol"},{"key":"5774_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.semarthrit.2016.05.010","volume":"46","author":"A Lackner","year":"2016","unstructured":"Lackner A, Duftner C, Ficjan A, Gretler J, Hermann J, Husic R, Graninger WB (2016) Dejaco C The association of clinical parameters and ultrasound verified inflammation with patients\u2019 and physicians\u2019 global assessments in psoriatic arthritis. Semin Arthritis Rheum 46:183\u2013189. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.010","journal-title":"Semin Arthritis Rheum"},{"key":"5774_CR8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.semarthrit.2017.10.021","volume":"47","author":"PJ Mease","year":"2018","unstructured":"Mease PJ (2018) Coates LC Considerations for the definition of remission criteria in psoriatic arthritis. Semin Arthritis Rheum 47:786\u2013796. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.021","journal-title":"Semin Arthritis Rheum"},{"key":"5774_CR9","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1093\/rheumatology\/keaa145","volume":"59","author":"GE Fragoulis","year":"2020","unstructured":"Fragoulis GE, Evangelatos G, Konsta M (2020) Iliopoulos A Anterior chest wall involvement in psoriatic arthritis: a forgotten entity? Rheumatology (Oxford) 59:3113\u20133114. https:\/\/doi.org\/10.1093\/rheumatology\/keaa145","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","volume":"17","author":"O FitzGerald","year":"2015","unstructured":"FitzGerald O, Haroon M, Giles JT (2015) Winchester R Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17:115. https:\/\/doi.org\/10.1186\/s13075-015-0640-3","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 11","key":"5774_CR11","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/acr.20577","volume":"63","author":"PJ Mease","year":"2011","unstructured":"Mease PJ (2011) Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander\/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 63(Suppl 11):S64-85. https:\/\/doi.org\/10.1002\/acr.20577","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5774_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewe R (2009) Assessment of SpondyloArthritis international S ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818. https:\/\/doi.org\/10.1136\/ard.2008.100826","journal-title":"Ann Rheum Dis"},{"key":"5774_CR13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3899\/jrheum.151491","volume":"43","author":"S Brikman","year":"2016","unstructured":"Brikman S, Furer V, Wollman J, Borok S, Matz H, Polachek A, Elalouf O, Sharabi A, Kaufman I, Paran D (2016) Elkayam O The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study. J Rheumatol 43:1749\u20131754. https:\/\/doi.org\/10.3899\/jrheum.151491","journal-title":"J Rheumatol"},{"key":"5774_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","volume":"42","author":"D Kane","year":"2003","unstructured":"Kane D, Stafford L, Bresnihan B (2003) FitzGerald O A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 42:1460\u20131468. https:\/\/doi.org\/10.1093\/rheumatology\/keg384","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR15","doi-asserted-by":"publisher","first-page":"iv67","DOI":"10.1093\/rheumatology\/keaa408","volume":"59","author":"K Sharif","year":"2020","unstructured":"Sharif K, Bridgewood C, Dubash S, McGonagle D (2020) Intestinal and enthesis innate immunity in early axial spondyloarthropathy. Rheumatology (Oxford) 59:iv67\u2013iv78. https:\/\/doi.org\/10.1093\/rheumatology\/keaa408","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR16","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ (2008) Helliwell PS Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686\u2013691. https:\/\/doi.org\/10.1002\/art.23568","journal-title":"Arthritis Rheum"},{"key":"5774_CR17","doi-asserted-by":"publisher","first-page":"551684","DOI":"10.3389\/fmed.2020.551684","volume":"7","author":"A Fassio","year":"2020","unstructured":"Fassio A, Matzneller P (2020) Idolazzi L Recent advances in imaging for diagnosis, monitoring, and prognosis of psoriatic arthritis. Front Med (Lausanne) 7:551684. https:\/\/doi.org\/10.3389\/fmed.2020.551684","journal-title":"Front Med (Lausanne)"},{"key":"5774_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/ard.2003.018184","volume":"64","author":"JE Brockbank","year":"2005","unstructured":"Brockbank JE, Stein M, Schentag CT (2005) Gladman DD Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 64:188\u2013190. https:\/\/doi.org\/10.1136\/ard.2003.018184","journal-title":"Ann Rheum Dis"},{"key":"5774_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.semarthrit.2018.02.002","volume":"48","author":"GS Kaeley","year":"2018","unstructured":"Kaeley GS, Eder L, Aydin SZ, Gutierrez M (2018) Bakewell C Dactylitis: a hallmark of psoriatic arthritis. Semin Arthritis Rheum 48:263\u2013273. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.02.002","journal-title":"Semin Arthritis Rheum"},{"key":"5774_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","volume":"69","author":"PJ Mease","year":"2013","unstructured":"Mease PJ, Gladman DD, Papp KA, Khraishi MM, Thaci D, Behrens F, Northington R, Fuiman J, Bananis E, Boggs R (2013) Alvarez D Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics. J Am Acad Dermatol 69:729\u2013735. https:\/\/doi.org\/10.1016\/j.jaad.2013.07.023","journal-title":"J Am Acad Dermatol"},{"issue":"251\u2013265","key":"5774_CR21","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.jaad.2018.06.027","volume":"80","author":"F Alinaghi","year":"2019","unstructured":"Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP (2019) Egeberg A prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol 80(251\u2013265):e219. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.027","journal-title":"J Am Acad Dermatol"},{"key":"5774_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.berh.2018.08.004","volume":"32","author":"A Kerschbaumer","year":"2018","unstructured":"Kerschbaumer A, Smolen JS (2018) Aletaha D Disease activity assessment in patients with psoriatic arthritis. Best Pract Res Clin Rheumatol 32:401\u2013414. https:\/\/doi.org\/10.1016\/j.berh.2018.08.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5774_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2004.04.012","volume":"51","author":"RG Langley","year":"2004","unstructured":"Langley RG (2004) Ellis CN Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician\u2019s Global Assessment. J Am Acad Dermatol 51:563\u2013569. https:\/\/doi.org\/10.1016\/j.jaad.2004.04.012","journal-title":"J Am Acad Dermatol"},{"key":"5774_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","volume":"41","author":"A Ogdie","year":"2015","unstructured":"Ogdie A (2015) Weiss P The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am 41:545\u2013568. https:\/\/doi.org\/10.1016\/j.rdc.2015.07.001","journal-title":"Rheum Dis Clin North Am"},{"key":"5774_CR25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190923","author":"PJ Mease","year":"2020","unstructured":"Mease PJ, Liu M, Rebello S, McLean RR, Dube B, Glynn M, Hur P (2020) Ogdie A Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the corrona psoriatic arthritis\/spondyloarthritis registry. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.190923","journal-title":"J Rheumatol"},{"key":"5774_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3899\/jrheum.100857","volume":"38","author":"A Cauli","year":"2011","unstructured":"Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Ujfalussy I, Scarpa R, Marchesoni A, Taylor WJ, Spadaro A, Fernandez-Sueiro JL, Salvarani C, Kalden JR, Lubrano E, Carneiro S, Desiati F, Flynn JA, D\u2019Angelo S, Vacca A (2011) AW VANK, Catanoso MG, Gruenke M, Peluso R, Parsons WJ, Ferrara N, Contu P, Helliwell PS, Mease PJ, Group GPS Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol 38:898\u2013903. https:\/\/doi.org\/10.3899\/jrheum.100857","journal-title":"J Rheumatol"},{"key":"5774_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4081\/reumatismo.2005.283","volume":"57","author":"C Cervini","year":"2005","unstructured":"Cervini C, Leardini G, Mathieu A, Punzi L, Scarpa R (2005) Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients. Reumatismo 57:283\u2013290. https:\/\/doi.org\/10.4081\/reumatismo.2005.283","journal-title":"Reumatismo"},{"key":"5774_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s10067-020-05065-9","volume":"39","author":"M Haroon","year":"2020","unstructured":"Haroon M, Gallaghar P, Ahmad M (2020) FitzGerald O Elevated CRP even at the first visit to a rheumatologist is associated with long-term poor outcomes in patients with psoriatic arthritis. Clin Rheumatol 39:2951\u20132961. https:\/\/doi.org\/10.1007\/s10067-020-05065-9","journal-title":"Clin Rheumatol"},{"key":"5774_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13075-020-2111-8","volume":"22","author":"MV Sokolova","year":"2020","unstructured":"Sokolova MV, Simon D, Nas K, Zaiss MM, Luo Y, Zhao Y, Rech J (2020) Schett G A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations. Arthritis Res Ther 22:26. https:\/\/doi.org\/10.1186\/s13075-020-2111-8","journal-title":"Arthritis Res Ther"},{"key":"5774_CR30","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/1744666X.2020.1729129","volume":"16","author":"TA Boyd","year":"2020","unstructured":"Boyd TA, Eastman PS, Huynh DH, Qureshi F, Sasso EH, Bolce R, Temple J, Hillman J, Boyle DL (2020) Kavanaugh A Correlation of serum protein biomarkers with disease activity in psoriatic arthritis. Expert Rev Clin Immunol 16:335\u2013341. https:\/\/doi.org\/10.1080\/1744666X.2020.1729129","journal-title":"Expert Rev Clin Immunol"},{"key":"5774_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","volume":"14","author":"T Gudu","year":"2018","unstructured":"Gudu T (2018) Gossec L Quality of life in psoriatic arthritis. Expert Rev Clin Immunol 14:405\u2013417. https:\/\/doi.org\/10.1080\/1744666X.2018.1468252","journal-title":"Expert Rev Clin Immunol"},{"key":"5774_CR32","first-page":"1842","volume":"28","author":"KB Sokoll","year":"2001","unstructured":"Sokoll KB (2001) Helliwell PS Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28:1842\u20131846","journal-title":"J Rheumatol"},{"key":"5774_CR33","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/acr.23172","volume":"69","author":"C Desthieux","year":"2017","unstructured":"Desthieux C, Granger B, Balanescu AR, Balint P, Braun J, Canete JD, Heiberg T, Helliwell PS, Kalyoncu U, Kvien TK, Kiltz U, Niedermayer D, Otsa K, Scrivo R, Smolen J, Stamm TA, Veale DJ, de Vlam K, de Wit M (2017) Gossec L Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study. Arthritis Care Res (Hoboken) 69:1606\u20131611. https:\/\/doi.org\/10.1002\/acr.23172","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"5774_CR34","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s10067-019-04870-1","volume":"39","author":"ER Soriano","year":"2020","unstructured":"Soriano ER, Zazzetti F, Alves Pereira I, Maldonado Cocco J, Feijo Azevedo V, Guerra G, Bautista-Molano W, Casasola JC, Vega Morales D, Gil DR, Lobosco S (2020) Lawson F Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol 39:1859\u20131869. https:\/\/doi.org\/10.1007\/s10067-019-04870-1","journal-title":"Clin Rheumatol"},{"key":"5774_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3899\/jrheum.190122","volume":"95","author":"YY Leung","year":"2019","unstructured":"Leung YY, Orbai AM, Ogdie A, Coates LC, de Wit M, Callis Duffin K, Eder L, Gladman DD, Goel N, Mease PJ, Strand V, FitzGerald O (2019) Tillett W The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: report and plan for completing the core outcome measurement set. J Rheumatol Suppl 95:33\u201337. https:\/\/doi.org\/10.3899\/jrheum.190122","journal-title":"J Rheumatol Suppl"},{"key":"5774_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.semarthrit.2017.09.002","volume":"47","author":"P Hojgaard","year":"2018","unstructured":"Hojgaard P, Klokker L, Orbai AM, Holmsted K, Bartels EM, Leung YY, Goel N, de Wit M, Gladman DD, Mease P, Dreyer L, Kristensen LE, FitzGerald O, Tillett W, Gossec L, Helliwell P, Strand V, Ogdie A, Terwee CB (2018) Christensen R A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: a GRAPPA-OMERACT initiative. Semin Arthritis Rheum 47:654\u2013665. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.002","journal-title":"Semin Arthritis Rheum"},{"key":"5774_CR37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3899\/jrheum.181077","volume":"46","author":"AM Orbai","year":"2019","unstructured":"Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Hojgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D (2019) Gladman DD PsAID12 provisionally endorsed at OMERACT 2018 as core outcome measure to assess psoriatic arthritis-specific health-related quality of life in clinical trials. J Rheumatol 46:990\u2013995. https:\/\/doi.org\/10.3899\/jrheum.181077","journal-title":"J Rheumatol"},{"key":"5774_CR38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","volume":"77","author":"U Kiltz","year":"2018","unstructured":"Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S (2018) Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Ann Rheum Dis 77:1311\u20131317. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212076","journal-title":"Ann Rheum Dis"},{"key":"5774_CR39","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/rheumatology\/keaa626","volume":"60","author":"I Morante","year":"2021","unstructured":"Morante I, Aurrecoechea E, Villa I, Santos M, Riancho L (2021) Queiro R Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis. Rheumatology (Oxford) 60:1465\u20131473. https:\/\/doi.org\/10.1093\/rheumatology\/keaa626","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR40","first-page":"S48","volume":"33","author":"JS Smolen","year":"2015","unstructured":"Smolen JS, Schoels M (2015) Aletaha D Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. Clin Exp Rheumatol 33:S48-50","journal-title":"Clin Exp Rheumatol"},{"key":"5774_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/ard.2010.129379","volume":"70","author":"A Mumtaz","year":"2011","unstructured":"Mumtaz A, Gallagher P, Kirby B, Waxman R, Coates LC, Veale JD, Helliwell P (2011) FitzGerald O Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70:272\u2013277. https:\/\/doi.org\/10.1136\/ard.2010.129379","journal-title":"Ann Rheum Dis"},{"key":"5774_CR42","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","volume":"72","author":"PS Helliwell","year":"2013","unstructured":"Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K (2013) Walsh JA The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis 72:986\u2013991. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201341","journal-title":"Ann Rheum Dis"},{"key":"5774_CR43","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3899\/jrheum.140172","volume":"41","author":"PS Helliwell","year":"2014","unstructured":"Helliwell PS, FitzGerald O (2014) Fransen J Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response. J Rheumatol 41:1212\u20131217. https:\/\/doi.org\/10.3899\/jrheum.140172","journal-title":"J Rheumatol"},{"key":"5774_CR44","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/art.1780380602","volume":"38","author":"DT Felson","year":"1995","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V et al (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727\u2013735. https:\/\/doi.org\/10.1002\/art.1780380602","journal-title":"Arthritis Rheum"},{"key":"5774_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J (2010) Helliwell PS Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 69:48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053","journal-title":"Ann Rheum Dis"},{"key":"5774_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/art.40391","volume":"70","author":"LC Coates","year":"2018","unstructured":"Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ (2018) Helliwell PS Group for research and assessment of psoriasis and psoriatic arthritis\/outcome measures in rheumatology consensus-based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis. Arthritis Rheumatol 70:345\u2013355. https:\/\/doi.org\/10.1002\/art.40391","journal-title":"Arthritis Rheumatol"},{"key":"5774_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.181089","volume":"46","author":"A Duarte-Garcia","year":"2019","unstructured":"Duarte-Garcia A, Leung YY, Coates LC, Beaton D, Christensen R, Craig ET, de Wit M, Eder L, Fallon L, FitzGerald O, Gladman DD, Goel N, Holland R, Lindsay C, Maxwell L, Mease P, Orbai AM, Shea B, Strand V, Veale DJ, Tillett W (2019) Ogdie A Endorsement of the 66\/68 joint count for the measurement of musculoskeletal Disease activity: OMERACT 2018 psoriatic arthritis workshop report. J Rheumatol 46:996\u20131005. https:\/\/doi.org\/10.3899\/jrheum.181089","journal-title":"J Rheumatol"},{"key":"5774_CR48","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/rheumatology\/kez215","volume":"58","author":"K Wervers","year":"2019","unstructured":"Wervers K, Luime JJ, Tchetverikov I, Gerards AH, Kok MR, Appels CWY, van der Graaff WL, van Groenendael J, Korswagen LA, Veris-van Dieren JJ, Hazes JMW, Vis M (2019) for C Comparison of disease activity measures in early psoriatic arthritis in usual care. Rheumatology (Oxford) 58:2251\u20132259. https:\/\/doi.org\/10.1093\/rheumatology\/kez215","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Schols M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewe R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K (2018) van der Heijde D Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77:3\u201317. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211734","journal-title":"Ann Rheum Dis"},{"key":"5774_CR50","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","volume":"74","author":"P Mandl","year":"2015","unstructured":"Mandl P, Navarro-Compan V, Terslev L, Aegerter P, van der Heijde D, D\u2019Agostino MA, Baraliakos X, Pedersen SJ, Jurik AG, Naredo E, Schueller-Weidekamm C, Weber U, Wick MC, Bakker PA, Filippucci E, Conaghan PG, Rudwaleit M, Schett G, Sieper J, Tarp S, Marzo-Ortega H, Ostergaard M (2015) European League Against R EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 74:1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206971","journal-title":"Ann Rheum Dis"},{"key":"5774_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/1744666X.2016.1215245","volume":"13","author":"AJ Mathew","year":"2017","unstructured":"Mathew AJ, Coates LC, Danda D (2017) Conaghan PG Psoriatic arthritis: lessons from imaging studies and implications for therapy. Expert Rev Clin Immunol 13:133\u2013142. https:\/\/doi.org\/10.1080\/1744666X.2016.1215245","journal-title":"Expert Rev Clin Immunol"},{"key":"5774_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3899\/jrheum.180140","volume":"94","author":"L Eder","year":"2018","unstructured":"Eder L, Aydin SZ, Kaeley GS, Maksymowych WP (2018) Ostergaard M Options for assessing joints and entheses in psoriatic arthritis by ultrasonography and magnetic resonance imaging: how to move forward. J Rheumatol Suppl 94:44\u201347. https:\/\/doi.org\/10.3899\/jrheum.180140","journal-title":"J Rheumatol Suppl"},{"key":"5774_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/RHU.0000000000000558","volume":"23","author":"H Maldonado-Ficco","year":"2017","unstructured":"Maldonado-Ficco H, Sheane BJ, Thavaneswaran A, Chandran V (2017) Gladman DD Magnetic resonance imaging in psoriatic arthritis: a descriptive study of indications, features and effect on treatment change. J Clin Rheumatol 23:243\u2013245. https:\/\/doi.org\/10.1097\/RHU.0000000000000558","journal-title":"J Clin Rheumatol"},{"key":"5774_CR54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jbspin.2020.03.014","volume":"87","author":"PE Palominos","year":"2020","unstructured":"Palominos PE, Coates L, Kohem CL, Orbai AM, Smolen J, de Wit M, Kiltz U, Leung YY, Canete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Soubrier M, Aydin SZ, Gaydukova I, Kalyoncu U (2020) Gossec L Determinants of sleep impairment in psoriatic arthritis: an observational study with 396 patients from 14 countries. Joint Bone Spine 87:449\u2013454. https:\/\/doi.org\/10.1016\/j.jbspin.2020.03.014","journal-title":"Joint Bone Spine"},{"key":"5774_CR55","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/rheumatology\/kez305","volume":"59","author":"D McGagh","year":"2020","unstructured":"McGagh D (2020) Coates LC Assessment of the many faces of PsA: single and composite measures in PsA clinical trials. Rheumatology (Oxford) 59:i29\u2013i36. https:\/\/doi.org\/10.1093\/rheumatology\/kez305","journal-title":"Rheumatology (Oxford)"},{"key":"5774_CR56","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3899\/jrheum.170150","volume":"44","author":"A Ogdie","year":"2017","unstructured":"Ogdie A, de Wit M, Callis Duffin K, Campbell W, Chau J, Coates LC, Eder L, Elmamoun M, FitzGerald O, Gladman DD, Goel N, James J, Kalyoncu U, Latella J, Lindsay C, Mease PJ, O\u2019Sullivan D, Steinkoenig I, Strand V, Tillett W (2017) Orbai AM Defining outcome measures for psoriatic arthritis: a report from the GRAPPA-OMERACT working group. J Rheumatol 44:697\u2013700. https:\/\/doi.org\/10.3899\/jrheum.170150","journal-title":"J Rheumatol"},{"key":"5774_CR57","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/annrheumdis-2018-214737","volume":"78","author":"V Chandran","year":"2019","unstructured":"Chandran V, Abji F, Perruccio AV, Gandhi R, Li S, Cook RJ (2019) Gladman DD Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis 78:796\u2013801. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214737","journal-title":"Ann Rheum Dis"},{"key":"5774_CR58","doi-asserted-by":"publisher","first-page":"108318","DOI":"10.1016\/j.clim.2019.108318","volume":"211","author":"J Pouw","year":"2020","unstructured":"Pouw J, Leijten E, Radstake T (2020) Boes M Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: a review of literature. Clin Immunol 211:108318. https:\/\/doi.org\/10.1016\/j.clim.2019.108318","journal-title":"Clin Immunol"},{"key":"5774_CR59","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1007\/s10067-020-05132-1","volume":"39","author":"YJ Su","year":"2020","unstructured":"Su YJ (2020) Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing. Clin Rheumatol 39:3677\u20133684. https:\/\/doi.org\/10.1007\/s10067-020-05132-1","journal-title":"Clin Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05774-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05774-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T13:00:39Z","timestamp":1634389239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05774-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,18]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["5774"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05774-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,18]]},"assertion":[{"value":"19 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate."}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication."}},{"value":"None.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}